These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36991440)

  • 1. Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models.
    He D; Fu S; Ye B; Wang H; He Y; Li Z; Li J; Gao X; Liu D
    J Neuroinflammation; 2023 Mar; 20(1):86. PubMed ID: 36991440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
    Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D
    Front Immunol; 2018; 9():2527. PubMed ID: 30455692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narciclasine inhibits LPS-induced neuroinflammation by modulating the Akt/IKK/NF-κB and JNK signaling pathways.
    Zhao D; Zhang LJ; Huang TQ; Kim J; Gu MY; Yang HO
    Phytomedicine; 2021 May; 85():153540. PubMed ID: 33773188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms.
    Fu SP; Wang JF; Xue WJ; Liu HM; Liu BR; Zeng YL; Li SN; Huang BX; Lv QK; Wang W; Liu JX
    J Neuroinflammation; 2015 Jan; 12():9. PubMed ID: 25595674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models.
    Liu Z; Shen C; Li H; Tong J; Wu Y; Ma Y; Wang J; Wang Z; Li Q; Zhang X; Dong H; Yang Y; Yu M; Wang J; Zhou R; Fei J; Huang F
    J Neuroinflammation; 2023 Apr; 20(1):96. PubMed ID: 37072793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
    Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
    Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
    Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early glycolytic reprogramming controls microglial inflammatory activation.
    Cheng J; Zhang R; Xu Z; Ke Y; Sun R; Yang H; Zhang X; Zhen X; Zheng LT
    J Neuroinflammation; 2021 Jun; 18(1):129. PubMed ID: 34107997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway.
    Cai L; Gong Q; Qi L; Xu T; Suo Q; Li X; Wang W; Jing Y; Yang D; Xu Z; Yuan F; Tang Y; Yang G; Ding J; Chen H; Tian H
    Cell Commun Signal; 2022 Apr; 20(1):56. PubMed ID: 35461293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural bear bile powder suppresses neuroinflammation in lipopolysaccharide-treated mice via regulating TGR5/AKT/NF-κB signaling pathway.
    Zhu H; Wang G; Bai Y; Tao Y; Wang L; Yang L; Wu H; Huang F; Shi H; Wu X
    J Ethnopharmacol; 2022 May; 289():115063. PubMed ID: 35149130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-1 attenuates neurodegeneration in Parkinson's disease model by modulating microglial MAPK/IκB/NFκB axis through its carbohydrate-recognition domain.
    Li Y; Chen N; Wu C; Lu Y; Gao G; Duan C; Yang H; Lu L
    Brain Behav Immun; 2020 Jan; 83():214-225. PubMed ID: 31669519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoliquiritigenin inhibits microglia-mediated neuroinflammation in models of Parkinson's disease via JNK/AKT/NFκB signaling pathway.
    Bai Y; Zhou J; Zhu H; Tao Y; Wang L; Yang L; Wu H; Huang F; Shi H; Wu X
    Phytother Res; 2023 Mar; 37(3):848-859. PubMed ID: 36484427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models.
    Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y
    Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
    Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camptothecin Regulates Microglia Polarization and Exerts Neuroprotective Effects
    He D; Fu S; Zhou A; Su Y; Gao X; Zhang Y; Huang B; Du J; Liu D
    Front Immunol; 2021; 12():619761. PubMed ID: 33868235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson's disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway.
    Huang B; Hu G; Zong X; Yang S; He D; Gao X; Liu D
    Int Immunopharmacol; 2023 Feb; 115():109698. PubMed ID: 36634417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson's disease.
    Guo L; Li Y; Li W; Qiu J; Du J; Wang L; Zhang T
    Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1221-1231. PubMed ID: 36054693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EriB targeted inhibition of microglia activity attenuates MPP
    Dou F; Chu X; Zhang B; Liang L; Lu G; Ding J; Chen S
    Mol Brain; 2018 Dec; 11(1):75. PubMed ID: 30563578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.